The AMA issued separate codes for subfascial and subcutaneous implantation of a tibial neuromodulation device.
|Articles|July 1, 2003
Multiple procedures, two physicians: Here's how to bill
Author(s)Ray Painter, MD
In a previous issue of Urology Times, this column discussed multiple procedures and the bundling edits for a single physician ("When to bill and not to bill for multiple procedures," May 2002, page 62). This article will address multiple procedures performed at the same encounter by two separate physicians.
Advertisement
Advertisement
Related to this article
Take a look through some of the notable data presentations at this year's ESMO Congress.
The investigational HIF-2α inhibitor casdatifan demonstrated antitumor activity as monotherapy and in combination regimens across the ARC-20 platform study.
The agency issued a PDUFA target action date of June 14, 2027.
Jeffrey M. Spier, MD, reviews evidence on ARPI dose reduction in prostate cancer and discusses monitoring treatment response, tolerability, and dose reescalation.
Jeffrey M. Spier, MD, discusses managing ARPI-related fatigue through dose adjustments, patient monitoring, and strategies to maintain treatment adherence.
Long-term QUILT-3.032 findings show durable responses with Anktiva plus BCG in BCG-unresponsive NMIBC, with an estimated 84.2% cystectomy-free survival at 3 years.
Vignesh Packiam, MD, discusses strategies to manage intravesical therapy toxicity in NMIBC, improve treatment tolerability, and preserve bladder function.
Advertisement
Advertisement
Trending on Urology Times
1
FDA accepts new drug application for UGN-103 in recurrent LG-IR-NMIBC
2
Jeffrey M. Spier, MD, on the evidence for reduced-dose enzalutamide
3
Prostate Cancer Case Review: Selecting Radioligand Therapy Candidates
4
Prostate Cancer Case Review: PSMA PET Before Definitive Therapy
5